Its not complicated, but it demands meticulous attention to detail
(etc) [DOI] [PubMed] [Google Scholar] 158.Kumar A.;, Smith P.J
49 However, the phenomenon of sequential reactivity in skin sensitizers was discussed in a review by Natsch and Emter in 2017 50 and further explored in a recent review on skin sensitization Adverse Outcome Pathway (AOP)
Supplemental Figure S2, In the STRIDE and durvalumab monotherapy arms, grade 3 or higher imAEs occurred in 2 (0.5%) and 4 (1.0%) participants within 36 months after treatment initiation, and in 7 (1.8%) and 4 (1.0%) participants at least 6 months after treatment initiation, respectively
More knowledge on how to minimise the effects of Covid-19, should we catch it, would not hurt either
Results may vary based on patient follow-ups, lifestyle changes and adherence to prescribed protocols